Release Notes: Version 20201008
About this release
This release (version 20201008) provides the latest updates to the Canadian Clinical Drug Data Set in English and French. A separate InfoScribe location for the French supporting documents, including the French Release Notes, can be found here.
There is no change to the Technical Specification or the Editorial Guidelines.
The Canadian Clinical Drug Data Set is available for browsing and download via the Infoway Terminology Gateway.
Supporting general information can be found on Infoway Canadian Clinical Drug Data Set InfoCentral page.
General Notes
The following files are available as full release files within this version:
- Manufactured Product,
- Non-proprietary Therapeutic Product,
- Therapeutic Moiety,
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in English (MP-NTP-TM Relationship),
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in French (Relation PM-PTC-FT),
- Special Groupings,
- Coded Attribute, and
- Device Non-proprietary Therapeutic Product.
The "Full" release contains one entry for every concept that has ever been released and new content added for that release. New content added for a specific release may at times include “Inactive” content.
NOTE: The “Delta" release which is intended to contain only those concepts that have been added or changed since the previous release will be considered for a future enhancement at a later date.
This release reflects additions and changes that have occurred in DPD since the last CCDD release.
NTP
There are 2 new deprecated NTP concepts with this release. In the first concept, the dosage form and strength expression for the corresponding product changed in DPD. In the second concept, the dosage form was corrected to reflect the administrable dose form.
| 9013845 | acetaminophen 1000 mg per 30 mL and chlorpheniramine maleate 4 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and pseudoephedrine hydrochloride 60 mg per 30 mL oral solution | acétaminophène 1000 mg par 30 mL et maléate de chlorphéniramine 4 mg par 30 mL et bromhydrate de dextrométhorphane 30 mg par 30 mL et chlorhydrate de pseudoéphédrine 60 mg par 30 mL solution orale | Deprec | 9014351 | acetaminophen 500 mg per 15 mL and chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup | acétaminophène 500 mg par 15 mL et maléate de chlorphéniramine 2 mg par 15 mL et bromhydrate de dextrométhorphane 15 mg par 15 mL et chlorhydrate de pseudoéphédrine 30 mg par 15 mL sirop |
9002810 | fluconazole 50 mg per 5 mL powder for oral solution | fluconazole 50 mg par 5 mL poudre pour solution orale | Deprec | 9014361 | fluconazole 50 mg per 5 mL oral solution | fluconazole 50 mg par 5 mL solution orale |
ntp_code | ntp_formal_name | ntp_fr_description | Type of change | Replaced with ntp_code | Replaced with ntp_formal_name | Replaced with ntp_fr_description |
|---|
MP
Two MP formal name changes have occurred as a result of the deprecated NTPs.
| 2291371 | ROBITUSSIN TOTAL COUGH, COLD & FLU NIGHTTIME EXTRA STRENGTH (acetaminophen 500 mg per 15 mL and chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | ROBITUSSIN TOTAL COUGH, COLD & FLU NIGHTTIME EXTRA STRENGTH (acétaminophène 500 mg par 15 mL et maléate de chlorphéniramine 2 mg par 15 mL et bromhydrate de dextrométhorphane 15 mg par 15 mL et chlorhydrate de pseudoéphédrine 30 mg par 15 mL sirop) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | ROBITUSSIN TOTAL COUGH, COLD & FLU NIGHTTIME EXTRA STRENGTH (acetaminophen 1000 mg per 30 mL and chlorpheniramine maleate 4 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and pseudoephedrine hydrochloride 60 mg per 30 mL oral solution) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | ROBITUSSIN TOTAL COUGH, COLD & FLU NIGHTTIME EXTRA STRENGTH (acétaminophène 1000 mg par 30 mL et maléate de chlorphéniramine 4 mg par 30 mL et bromhydrate de dextrométhorphane 30 mg par 30 mL et chlorhydrate de pseudoéphédrine 60 mg par 30 mL solution orale) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC |
| 2024152 | DIFLUCAN (fluconazole 50 mg per 5 mL oral solution) PFIZER CANADA ULC | DIFLUCAN (fluconazole 50 mg par 5 mL solution orale) PFIZER CANADA ULC | DIFLUCAN (fluconazole 50 mg per 5 mL powder for oral solution) PFIZER CANADA ULC | DIFLUCAN (fluconazole 50 mg par 5 mL poudre pour solution orale) PFIZER CANADA ULC |
mp_code | mp_formal_name October Release | mp_fr_description October Release | mp_formal_name September Release | mp_fr_description September Release |
|---|
Questions, Concerns, Changes
Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]